MMRF

The Multiple Myeloma Research Foundation launched the MMRF Answer Fund to engage researchers, clinicians, and patients in the search for better treatments.

The Genomic Data Commons, the MMRF, and the Project GENIE are all inking new arrangements around sharing genomics data and crowdsourcing analysis.  

The NCI Genomic Data Commons was launched this summer to  to centralize, standardize, and make available genomic and molecular data from various research programs.

The partners said they will use genetic sequencing and a combination therapy to determine predictors of sustained minimal residual disease negativity.

The partners will compare Adaptive Bio's clonoSeq MRD test with flow cytometry for accuracy and reliability in monitoring MRD in multiple myeloma patients. 

GNS Healthcare and the Multiple Myeloma Research Foundation to use GNS' informatics solutions to explore genomic and clinical data from the CoMMpass study.

This article has been corrected to note that the next-generation sequencing component of the trial is currently observational only.

The American Association for Cancer Research has named personalized breast cancer treatment expert Jose Baselga as its new president-elect.

Peter Kim, former Merck Research Laboratories president, will return to his alma mater Stanford University as a professor of biochemistry at the School of Medicine.

The Multiple Myeloma Research Foundation is hoping that an open-access research portal containing detailed longitudinal clinical and genomic data from multiple myeloma patients will spur collaborative research that advances much needed molecularly-targeted treatments.

Pages

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.